Hudson Valley iCampus, New York’s hub for innovation, ingenuity and industry, has announced that it has signed three new leases and two expansion agreements in the first quarter of 2024, totaling 35,124 square feet and having a value of over $4 million.

“Many of the deals were for laboratory uses,” said Jamie Schwartz, president of Hudson Valley iCampus. “Although the headlines report life sciences and biotech investments slowing due to high interest rates and other factors, we continue to experience brisk leasing activity from both large and small companies.”

RK Pharma Inc., an American multinational pharmaceutical and biotechnology corporation that focuses on the development, manufacturing and sale of high quality and affordable generic pharmaceutical products worldwide, leased an additional 22,584 square feet of stability chamber space in Building 100. RK Pharma also leases 82,975 square feet of laboratory, manufacturing, and office space in Buildings 215 and 215A.